Musculoskeletal Disorders and Associated Factors Among Patients with Chronic Kidney Disease Attending at Saint Paul Hospital, Addis Ababa, Ethiopia
Open Access
- 1 August 2021
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nephrology and Renovascular Disease
- Vol. ume 14, 291-300
Abstract
Background: Musculoskeletal disorders contributed from chronic kidney disease are increasing worldwide. Musculoskeletal disorders had a significant health burden and are leading causes of co-morbidities, disability and low productivity, which potentially affect individual’s functional status and quality of life. Purpose: The aim of this study was to assess the prevalence of musculoskeletal disorders and its associated factors among patients with chronic kidney attending in Saint Paul Hospital, Addis Ababa, Ethiopia. Patients and Methods: An institution-based cross-sectional study was conducted on 302 enrolled study participants through systematic random sampling techniques. Face-to-face interview, physical examination and chart reviews were used to collect data using semi-structured questionnaire adapted from a standard Nordic Musculoskeletal Questionnaire and other literatures. Data were entered into Epi Info version 7 and exported to SPSS version 23 for analysis. Bivariate logistic regression analysis was employed with a p-value less than 0.25. Finally, those variables having a p-value less than 0.05 with 95% CI in multivariate analysis were taken as statistically significant. Results: The prevalence of musculoskeletal disorders among CKD individuals was found to be 58.6% (95% CI; 53.0, 64.1). Being female (AOR = 0.49; 95% CI 0.26, 0.94), age between 40 and 49 (AOR = 3.34; 95% CI 1.07, 10.44), stage III (AOR = 0.24; 95% CI 0.06, 0.89) and stage IV (AOR = 0.24; 95% CI 0.06, 0.89) chronic kidney disease, having HTN (AOR = 7.47; 95% CI 3.47, 16.06), parathyroid hormone level ≥ 100 pg/mL (AOR = 0.43; 95% CI 0.21, 0.87), calcium level < 8.4 mg/dl (AOR = 5.89; 95% CI 2.66, 13.56) and serum 25 hydroxy vitamin D level < 20 ng/mL (AOR = 3.91; 95% CI 1.32, 11.56) were significantly associated with musculoskeletal disorders. Conclusion: MSDs were shown to be moderately common in CKD patients. Female gender, age between 40 and 49 yrs, stage III and stage IV CKD, hypertension, higher PTH level, lower calcium level and lower vitamin D level were statistically significant in their association with musculoskeletal disorders.Keywords
This publication has 29 references indexed in Scilit:
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Various musculoskeletal manifestations of chronic renal insufficiencyClinical Radiology, 2013
- Musculoskeletal Disorders in the ElderlyJournal of Clinical Imaging Science, 2012
- Radiological Imaging Features of Fasciola hepatica Infection – A Pictorial ReviewJournal of Clinical Imaging Science, 2012
- Risk factors for work‐related musculoskeletal disorders: a systematic review of recent longitudinal studiesAmerican Journal of Industrial Medicine, 2009
- Pain management in patients with chronic kidney diseaseClinical Kidney Journal, 2009
- Pain, Sleep Disturbance, and Quality of Life in Patients with Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2007
- Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2005
- Osteoarticular disorders of renal origin: disease-related and iatrogenicBest Practice & Research Clinical Rheumatology, 2000
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980